藥品安全市場：按功能（ADR 報告、藥品安全審核、完全整合軟體）、按交付型態（按需、內部部署）、按最終用戶分類 - 2023-2030 年全球預測

全球藥品安全市場預計將大幅成長，預計2023年將達到115.6364億美元，年複合成長率為21.68%，預計2030年將達到457.4638億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球藥品安全市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 全球藥品安全市場規模及預測為何？

2. 在預測期內，COVID-19 對全球藥品安全市場的阻礙因素與影響有哪些？

3. 預測期內全球藥品安全市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球藥品安全市場的競爭策略是什麼？

5. 全球藥品安全市場的技術趨勢和法律規範是什麼？

6.全球藥品安全市場主要廠商的市佔率為何？

7. 哪些型態和策略措施被認為適合進入全球藥品安全市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 吸煙成癮症的人口增加
    • 病人安全問題日益嚴重
    • 玩家對外包服務的需求不斷成長
  • 抑制因素
    • 臨床試驗問題
  • 機會
    • 活性化研發活動
    • 提高藥物安全性，推動新藥上市
  • 任務
    • 藥物副作用
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 藥品安全市場的功能

• ADR 報告
• 藥品安全審核
• 完全整合的軟體
• 問題追蹤

第7章 依交付模式分類的藥品安全市場

• 一經請求
• 本地

第8章 藥品安全市場：依最終用戶分類

• 業務流程外包
• 合約研究組織
• 製藥和生物技術公司

第9章 美洲藥品安全市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太藥品安全市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲藥品安全市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Drug Safety Market is forecasted to grow significantly, with a projected USD 11,563.64 million in 2023 at a CAGR of 21.68% and expected to reach a staggering USD 45,746.38 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Safety Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Safety Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Functionality, market is studied across ADR Reporting, Drug Safety Audits, Fully Integrated Software, and Issue Tracking. The Fully Integrated Software is projected to witness significant market share during forecast period.

Based on Delivery Mode, market is studied across On-Demand and On-Premise. The On-Demand is projected to witness significant market share during forecast period.

Based on End User, market is studied across Business Process Outsourcing, Contract Research Organizations, and Pharma & Biotech Companies. The Contract Research Organizations is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Safety Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Safety Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Safety Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Safety Market?

4. What is the competitive strategic window for opportunities in the Global Drug Safety Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Safety Market?

6. What is the market share of the leading vendors in the Global Drug Safety Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Safety Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Drug Safety Market, by Functionality, 2022 vs 2030
• 4.3. Drug Safety Market, by Delivery Mode, 2022 vs 2030
• 4.4. Drug Safety Market, by End User, 2022 vs 2030
• 4.5. Drug Safety Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing population addicted to smoking
    • 5.1.1.2. Escalating patient safety issues
    • 5.1.1.3. Rise in demand for outsourcing services by players
  • 5.1.2. Restraints
    • 5.1.2.1. Issues related to clinical trials
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising R&D activities
    • 5.1.3.2. Increasing adoption of drug safety facilitating the launch of new drugs
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects of drugs
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Drug Safety Market, by Functionality

• 6.1. Introduction
• 6.2. ADR Reporting
• 6.3. Drug Safety Audits
• 6.4. Fully Integrated Software
• 6.5. Issue Tracking

7. Drug Safety Market, by Delivery Mode

• 7.1. Introduction
• 7.2. On-Demand
• 7.3. On-Premise

8. Drug Safety Market, by End User

• 8.1. Introduction
• 8.2. Business Process Outsourcing
• 8.3. Contract Research Organizations
• 8.4. Pharma & Biotech Companies

9. Americas Drug Safety Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug Safety Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug Safety Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. DRUG SAFETY MARKET RESEARCH PROCESS
• FIGURE 2. DRUG SAFETY MARKET SIZE, 2022 VS 2030
• FIGURE 3. DRUG SAFETY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2022 VS 2030 (%)
• FIGURE 5. DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2022 VS 2030 (%)
• FIGURE 6. DRUG SAFETY MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 7. DRUG SAFETY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. DRUG SAFETY MARKET DYNAMICS
• FIGURE 9. DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. DRUG SAFETY MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. DRUG SAFETY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. DRUG SAFETY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. DRUG SAFETY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 5. DRUG SAFETY MARKET SIZE, BY ADR REPORTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. DRUG SAFETY MARKET SIZE, BY DRUG SAFETY AUDITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. DRUG SAFETY MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. DRUG SAFETY MARKET SIZE, BY ISSUE TRACKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 10. DRUG SAFETY MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. DRUG SAFETY MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 13. DRUG SAFETY MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. DRUG SAFETY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS , BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. DRUG SAFETY MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. CANADA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 27. CANADA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. CHINA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 44. CHINA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. INDIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 47. INDIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ITALY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 99. ITALY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. POLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 111. POLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. QATAR DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 114. QATAR DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. DRUG SAFETY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 144. DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 145. DRUG SAFETY MARKET LICENSE & PRICING